Nanotechnology integration for sars-cov-2 diagnosis and treatment: An approach to preventing pandemic
The SARS-CoV-2 outbreak is the COVID-19 disease, which has caused massive health devastation, prompting the World Health Organization to declare a worldwide health emergency. The corona virus infected millions of people worldwide, and many died as a result of a lack of particular medications. The cu...
Saved in:
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Article PeerReviewed |
Language: | English English English |
Published: |
Multidisciplinary Digital Publishing Institute (MDPI)
2021
|
Subjects: | |
Online Access: | https://repository.unair.ac.id/125498/1/Artikel%20C-26.pdf https://repository.unair.ac.id/125498/2/Kualitas%20Karil%20C-26.pdf https://repository.unair.ac.id/125498/3/C-26_artikel_similarity.pdf https://repository.unair.ac.id/125498/ https://www.mdpi.com/2079-4991/11/7/1841 https://doi.org/10.3390/nano11071841 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Universitas Airlangga |
Language: | English English English |
id |
id-langga.125498 |
---|---|
record_format |
dspace |
spelling |
id-langga.1254982023-04-29T03:48:38Z https://repository.unair.ac.id/125498/ Nanotechnology integration for sars-cov-2 diagnosis and treatment: An approach to preventing pandemic Syed Mohammed Basheeruddin Asdaq, - Abu Md Ashif Ikbal, - Ram Kumar Sahu, - Bedanta Bhattacharjee, - Tirna Paul, - Bhargab Deka, - Santosh Fattepur, - Retno Widyowati, - Joshi Vijaya, - Mohammed Al mohaini, - Abdulkhaliq J Alsalman, - Mohd Imran, - Sreeharsha Nagaraja, - Anroop B. Nair, - Mahesh Attimarad, - Katharigatta N. Venugopala, - R Medicine RS Pharmacy and materia medica RS1-441 Pharmacy and materia medica RS200-201 Pharmaceutical dosage forms The SARS-CoV-2 outbreak is the COVID-19 disease, which has caused massive health devastation, prompting the World Health Organization to declare a worldwide health emergency. The corona virus infected millions of people worldwide, and many died as a result of a lack of particular medications. The current emergency necessitates extensive therapy in order to stop the spread of the coronavirus. There are various vaccinations available, but no validated COVID-19 treatments. Since its outbreak, many therapeutics have been tested, including the use of repurposed medications, nucleoside inhibitors, protease inhibitors, broad spectrum antivirals, convalescence plasma therapies, immune-modulators, and monoclonal antibodies. However, these approaches have not yielded any outcomes and are mostly used to alleviate symptoms associated with potentially fatal adverse drug reactions. Nanoparticles, on the other hand, may prove to be an effective treatment for COVID-19. They can be designed to boost the efficacy of currently available antiviral medications or to trigger a rapid immune response against COVID-19. In the last decade, there has been significant progress in nanotechnology. This review focuses on the virus’s basic structure, pathogenesis, and current treatment options for COVID-19. This study addresses nanotechnology and its applications in diagnosis, prevention, treatment, and targeted vaccine delivery, laying the groundwork for a successful pandemic fight. Multidisciplinary Digital Publishing Institute (MDPI) 2021-07-16 Article PeerReviewed text en https://repository.unair.ac.id/125498/1/Artikel%20C-26.pdf text en https://repository.unair.ac.id/125498/2/Kualitas%20Karil%20C-26.pdf text en https://repository.unair.ac.id/125498/3/C-26_artikel_similarity.pdf Syed Mohammed Basheeruddin Asdaq, - and Abu Md Ashif Ikbal, - and Ram Kumar Sahu, - and Bedanta Bhattacharjee, - and Tirna Paul, - and Bhargab Deka, - and Santosh Fattepur, - and Retno Widyowati, - and Joshi Vijaya, - and Mohammed Al mohaini, - and Abdulkhaliq J Alsalman, - and Mohd Imran, - and Sreeharsha Nagaraja, - and Anroop B. Nair, - and Mahesh Attimarad, - and Katharigatta N. Venugopala, - (2021) Nanotechnology integration for sars-cov-2 diagnosis and treatment: An approach to preventing pandemic. Nanomaterials, 11 (7). pp. 1-27. ISSN 2079-4991 https://www.mdpi.com/2079-4991/11/7/1841 https://doi.org/10.3390/nano11071841 |
institution |
Universitas Airlangga |
building |
Universitas Airlangga Library |
continent |
Asia |
country |
Indonesia Indonesia |
content_provider |
Universitas Airlangga Library |
collection |
UNAIR Repository |
language |
English English English |
topic |
R Medicine RS Pharmacy and materia medica RS1-441 Pharmacy and materia medica RS200-201 Pharmaceutical dosage forms |
spellingShingle |
R Medicine RS Pharmacy and materia medica RS1-441 Pharmacy and materia medica RS200-201 Pharmaceutical dosage forms Syed Mohammed Basheeruddin Asdaq, - Abu Md Ashif Ikbal, - Ram Kumar Sahu, - Bedanta Bhattacharjee, - Tirna Paul, - Bhargab Deka, - Santosh Fattepur, - Retno Widyowati, - Joshi Vijaya, - Mohammed Al mohaini, - Abdulkhaliq J Alsalman, - Mohd Imran, - Sreeharsha Nagaraja, - Anroop B. Nair, - Mahesh Attimarad, - Katharigatta N. Venugopala, - Nanotechnology integration for sars-cov-2 diagnosis and treatment: An approach to preventing pandemic |
description |
The SARS-CoV-2 outbreak is the COVID-19 disease, which has caused massive health devastation, prompting the World Health Organization to declare a worldwide health emergency. The corona virus infected millions of people worldwide, and many died as a result of a lack of particular medications. The current emergency necessitates extensive therapy in order to stop the spread of the coronavirus. There are various vaccinations available, but no validated COVID-19 treatments. Since its outbreak, many therapeutics have been tested, including the use of repurposed medications, nucleoside inhibitors, protease inhibitors, broad spectrum antivirals, convalescence plasma therapies, immune-modulators, and monoclonal antibodies. However, these approaches have not yielded any outcomes and are mostly used to alleviate symptoms associated with potentially fatal adverse drug reactions. Nanoparticles, on the other hand, may prove to be an effective treatment for COVID-19. They can be designed to boost the efficacy of currently available antiviral medications or to trigger a rapid immune response against COVID-19. In the last decade, there has been significant progress in nanotechnology. This review focuses on the virus’s basic structure, pathogenesis, and current treatment options for COVID-19. This study addresses nanotechnology and its applications in diagnosis, prevention, treatment, and targeted vaccine delivery, laying the groundwork for a successful pandemic fight. |
format |
Article PeerReviewed |
author |
Syed Mohammed Basheeruddin Asdaq, - Abu Md Ashif Ikbal, - Ram Kumar Sahu, - Bedanta Bhattacharjee, - Tirna Paul, - Bhargab Deka, - Santosh Fattepur, - Retno Widyowati, - Joshi Vijaya, - Mohammed Al mohaini, - Abdulkhaliq J Alsalman, - Mohd Imran, - Sreeharsha Nagaraja, - Anroop B. Nair, - Mahesh Attimarad, - Katharigatta N. Venugopala, - |
author_facet |
Syed Mohammed Basheeruddin Asdaq, - Abu Md Ashif Ikbal, - Ram Kumar Sahu, - Bedanta Bhattacharjee, - Tirna Paul, - Bhargab Deka, - Santosh Fattepur, - Retno Widyowati, - Joshi Vijaya, - Mohammed Al mohaini, - Abdulkhaliq J Alsalman, - Mohd Imran, - Sreeharsha Nagaraja, - Anroop B. Nair, - Mahesh Attimarad, - Katharigatta N. Venugopala, - |
author_sort |
Syed Mohammed Basheeruddin Asdaq, - |
title |
Nanotechnology integration for sars-cov-2 diagnosis and treatment: An approach to preventing pandemic |
title_short |
Nanotechnology integration for sars-cov-2 diagnosis and treatment: An approach to preventing pandemic |
title_full |
Nanotechnology integration for sars-cov-2 diagnosis and treatment: An approach to preventing pandemic |
title_fullStr |
Nanotechnology integration for sars-cov-2 diagnosis and treatment: An approach to preventing pandemic |
title_full_unstemmed |
Nanotechnology integration for sars-cov-2 diagnosis and treatment: An approach to preventing pandemic |
title_sort |
nanotechnology integration for sars-cov-2 diagnosis and treatment: an approach to preventing pandemic |
publisher |
Multidisciplinary Digital Publishing Institute (MDPI) |
publishDate |
2021 |
url |
https://repository.unair.ac.id/125498/1/Artikel%20C-26.pdf https://repository.unair.ac.id/125498/2/Kualitas%20Karil%20C-26.pdf https://repository.unair.ac.id/125498/3/C-26_artikel_similarity.pdf https://repository.unair.ac.id/125498/ https://www.mdpi.com/2079-4991/11/7/1841 https://doi.org/10.3390/nano11071841 |
_version_ |
1765216200719073280 |